Opinions in Hematology

What?

Opinions in Hematology’ is a full colour printed publication series of 8 pages consisting of a state of the art introduction on a specific medical topic relevant for clinicians working in Hematology, followed by interviews with leading opinion leaders in the field, who are sharing their opinion with readers on latest developments and new insights related to the medical issue at hand.

Clients

Incyte Biosciences & Novartis Pharma

Indication

Chronic Myeloid Leukemia (CML)

Target audience

Hematologists

Goal

Educating hematologists on a new guideline for diagnosing and treating CML thus accelerating the uptake of new practices by hospital staff.

Solution

In the series ‘Opinions in Hematology’ leading hematologists in the Netherlands extrapolate new scientific insights to daily clinical practice. Each publication is 8 pages in print, with state-of-the art texts and interviews.

Result

Faster application of the new guideline in clinical setting.